FAP, May 16 / PRNewswire-Asianet /-- the National Institutes of Health (NIH) will conduct initial clinical trials of a new vaccine based on mRNA technology that can prevent influenza caused by all known strains of the virus, and is recruiting volunteers, according to CNBC.
According to CNBC, the National Institutes of Health (NIH) will conduct initial clinical trials of a new vaccine based on mRNA technology that can prevent influenza caused by all known strains of the virus, and is recruiting volunteers.